Gastroenterology - European Medical Journal

Continue

Gastroenterology

Filter
9 May 2017

Introducing EMJ Urology 5.1

United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is…
5 May 2017

Osimertinib Improves Symptoms in Advanced Lung Cancer Patients

Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis presented at the ELCC.
4 May 2017

European Commission Extends Approval for Janssen’s DARZALEX®▼(daratumumab) to Include Multiple Myeloma Patients Who Have Received at Least One Prior Therapy

Beerse, Belgium, 28 April, 2017 – Janssen-Cilag International NV (“Janssen”) today announced that the European Commission (EC) has granted approval to…
18 Apr 2017

RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®

Tel-Aviv, Israel, April 18, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…
5 Apr 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
5 Apr 2017

Low Vitamin D Levels Linked to Ulcerative Colitis Relapse

CLINICAL relapse risk amongst individuals with ulcerative colitis (UC) more common if the levels of vitamin D in the blood are lower than required…
5 Apr 2017

Connection Uncovered Between Gut Bacteria and Patient Behaviour

A POTENTIAL link has been discerned between gut bacteria and behaviour in patients with irritable bowel syndrome (IBS), a common gastrointestinal…
22 Mar 2017

RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease

Tel-Aviv, Israel, March 21, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…